marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Corbus Pharmaceuticals Holdings Financial Ratios 2011-2024 | CRBP
Annual Financial Ratios Corbus Pharmaceuticals Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.0 | -0.3 | -0.1 | -1.3 | -5.8 | -7.4 | -12.6 | -13.5 | -5.0 | -16.7 | - | - | - |
P/S |
- | - | 2.9 | 38.1 | 11.5 | 85.3 | 167.6 | 141.0 | 68.2 | - | - | - | - |
EPS |
-10.3 | -10.2 | -11.2 | -1.4 | -1.1 | -1.0 | -0.7 | -0.5 | -0.3 | -0.1 | -0.1 | - | - |
EV (Enterprise Value) |
66.5 M | 27.7 M | 16.1 M | 121 M | 426 M | 389 M | 356 M | 263 M | 35.8 M | 36.8 M | 1.79 M | - | - |
EBITDA per Share |
-10.3 | -9.37 | -13.4 | -1.48 | -1.19 | -0.987 | -0.644 | -0.484 | -0.281 | -0.131 | - | - | - |
EV/EBITDA |
-0.2 | -0.7 | -5.1 | -6.6 | -10.7 | -12.8 | -3.6 | -13.7 | - | - | - | ||
PEG |
-0.01 | -0.0 | -0.0 | 0.05 | 0.41 | 0.15 | 0.39 | 0.18 | 0.04 | 0.04 | - | - | - |
P/B |
-6.5 | 0.3 | 0.0 | 3.3 | 67.3 | 15.0 | 7.1 | 30.2 | 4.9 | 7.2 | - | - | - |
P/CF |
-1.2 | -0.3 | -0.1 | -1.5 | -8.6 | -12.7 | -14.3 | -19.4 | -9.3 | -17.5 | - | - | - |
ROE % |
645.98 | -128.36 | -66.04 | -245.76 | -1160.42 | -202.27 | -56.11 | -224.22 | -98.51 | -43.33 | - | - | - |
ROA % |
-157.76 | -63.86 | -42.37 | -108.77 | -145.40 | -118.48 | -48.41 | -111.80 | -68.74 | -38.49 | - | - | - |
ROCE % |
652.85 | -120.75 | -81.02 | -174.45 | -540.90 | -196.36 | -55.40 | -222.31 | -95.76 | -45.15 | - | - | - |
Current Ratio |
0.8 | 2.0 | 2.8 | 2.9 | 1.1 | 2.4 | 8.0 | 2.0 | 3.5 | 8.9 | - | - | - |
DSO |
- | - | - | 239.0 | 27.1 | - | - | 254.1 | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Corbus Pharmaceuticals Holdings
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.15 | -0.9 | -0.83 | - | -2.27 | -2.05 | -4.24 | - | -2.11 | -3.18 | -2.26 | - | -0.02 | -0.15 | -0.14 | - | -0.43 | -0.52 | -0.43 | - | -0.32 | 0.03 | -0.43 | - | -0.26 | -0.21 | -0.21 | -0.2 | -0.14 | -0.15 | -0.16 | -0.17 | -0.12 | -0.11 | -0.08 | - | -0.06 | -0.1 | -0.06 | - | -0.03 | -0.02 | -0.02 | - | -0.01 | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-1.27 | -0.98 | -1.14 | - | -2.1 | -1.87 | -4.09 | - | -1.92 | -2.91 | -2 | - | -0.1 | -0.14 | -0.13 | - | -0.41 | -0.51 | -0.43 | - | -0.39 | 0.03 | -0.43 | - | -0.26 | -0.21 | -0.21 | -0.2 | -0.14 | -0.14 | -0.16 | -0.17 | -0.12 | -0.11 | -0.08 | - | -0.06 | -0.1 | -0.06 | - | -0.03 | -0.02 | -0.02 | - | -0.01 | - | - | - | - | - | - | - | - | - | - |
ROE % |
-3246.35 | -6459.31 | -6543.60 | -3422.19 | -3443.12 | -241.94 | -176.47 | -63.15 | -65.95 | -47.82 | -43.31 | -42.63 | -119.70 | -193.97 | -255.87 | -226.74 | -564.39 | -824.96 | -705.84 | -728.75 | -781.79 | -497.20 | -576.01 | -139.39 | -157.90 | -116.90 | -85.68 | -56.11 | -122.48 | -170.37 | -204.71 | -224.22 | -164.43 | -129.57 | -111.12 | -70.70 | -81.95 | -68.11 | -48.20 | -21.84 | -18.50 | -3.91 | 4.70 | 3.34 | 3.34 | - | - | - | - | - | - | - | - | - | - |
ROA % |
-48.17 | -67.48 | -80.99 | -82.16 | -94.05 | -78.24 | -74.29 | -37.90 | -39.72 | -29.65 | -27.71 | -27.49 | -61.61 | -93.90 | -116.94 | -100.35 | -142.66 | -150.86 | -109.23 | -91.31 | -122.39 | -111.15 | -141.22 | -81.65 | -97.61 | -76.94 | -62.15 | -48.41 | -74.76 | -94.25 | -106.78 | -111.80 | -86.98 | -74.60 | -71.08 | -49.34 | -59.33 | -51.82 | -39.56 | -19.39 | -38.89 | -48.39 | -40.74 | -19.49 | -19.49 | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-3070.00 | -6100.73 | -6177.99 | -3232.13 | -3251.63 | -230.11 | -169.05 | -58.38 | -76.25 | -74.62 | -71.38 | -56.42 | -131.46 | -188.62 | -251.16 | -225.29 | -632.86 | -965.40 | -853.47 | -810.62 | -864.74 | -511.30 | -584.02 | -142.26 | -161.06 | -118.97 | -86.56 | -56.35 | -122.46 | -170.22 | -204.59 | -224.07 | -164.26 | -129.56 | -111.09 | -70.71 | -84.66 | -73.52 | -52.92 | -23.68 | -21.13 | -4.64 | 3.28 | 2.54 | 2.54 | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
12.0 | 5.8 | 4.4 | 0.8 | 1.0 | 1.3 | 1.5 | 2.0 | 2.3 | 2.5 | 2.8 | 2.8 | 2.9 | 2.8 | 2.9 | 1.8 | 1.8 | 1.8 | 1.8 | 1.1 | 1.1 | 1.1 | 1.1 | 2.4 | 2.4 | 2.4 | 2.4 | 7.3 | 7.3 | 7.3 | 7.3 | 2.0 | 2.0 | 2.0 | 2.0 | 3.3 | 3.3 | 3.3 | 3.3 | 8.9 | 8.9 | 11.1 | 8.9 | 0.3 | 0.3 | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency